Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 47 out of 100. Digital health tools

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Between September 1972 and January 1976 an outbreak of dialysis dementia affected 20 patients maintained by long-term hemodialysis. The clinical picture was characterized by an insidious onset of altered behaviour, dementia, speech disturbance, myoclonus, and convulsions. Nineteen patients died, but one patient has survived for 16 months. It was later established that in June 1972 the city had altered its method of water purification and that this resulted in higher water aluminum levels. The temporal relation between periods of high water-aluminum content and the appearance of new cases supports the view that aluminum may play a role in the causation of dialysis dementia.

What this study adds

Evidence grade: Low

The record lists 20 participants. This report describes an outbreak of dialysis dementia in 20 hemodialysis patients that coincided with higher water aluminum levels, supporting a possible role for aluminum in causing that condition. It concerns dialysis dementia and does not test any treatment, cure, or prevention for Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Dunea, G., Mahurkar, S. D., Mamdani, B., & Smith, E. C. (1978). Role of aluminum in dialysis dementia. Annals of internal medicine. https://doi.org/10.7326/0003-4819-88-4-502

Vancouver

Dunea G, Mahurkar SD, Mamdani B, Smith EC. Role of aluminum in dialysis dementia. Annals of internal medicine. 1978. doi:10.7326/0003-4819-88-4-502. PMID: 637430.

BibTeX

@article{dunea1978-637430,
  author  = {Dunea, G. and Mahurkar, S. D. and Mamdani, B. and Smith, E. C.},
  title   = {{Role of aluminum in dialysis dementia}},
  journal = {Annals of internal medicine},
  year    = {1978},
  doi     = {10.7326/0003-4819-88-4-502},
  pmid    = {637430},
  url     = {https://doi.org/10.7326/0003-4819-88-4-502}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This report describes an outbreak of dialysis dementia in 20 hemodialysis patients that coincided with higher water aluminum levels, supporting a possible role for aluminum in causing that condition. It concerns dialysis dementia and does not test any treatment, cure, or prevention for Alzheimer's disease.

Study details

How this study scored 47/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 5 of 7; Citations per year 2 of 5; Impact for its field and year 5 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 44 of the 93 points it could be judged on, which is 47 of 100. Total 47 of 100.44 of the 93 points we could judge = 47 of 100

Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 44 of the 93 points we could judge it on, which is 47 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Annals of internal medicine)
Journal's citation record 4 / 4 Annals of Internal Medicine: journal h-index 648 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 1978 — older than 20 years, still counted
Sample size 1 / 4 20 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 5 / 7 Cited 168 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 3.4 citations a year over 50 year(s) since 1978
Impact for its field and year 5 / 6 Cited 24.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 637430)
Free to read 0 / 2 Behind a paywall — scores zero
Points 44 / 93 Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 44 of the 93 points we could judge it on is 47 out of 100.
Total 47 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Digital health tools from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Digital health tools

See all studies in Digital health tools →